Use of electrochemical impedance spectroscopy (eis) in continuous glucose monitoring
US-2015164382-A1 · Jun 18, 2015 · US
US11974844B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11974844-B2 |
| Application number | US-201916397156-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 29, 2019 |
| Priority date | Dec 28, 2015 |
| Publication date | May 7, 2024 |
| Grant date | May 7, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.
Opening claim text (preview).
What is claimed is: 1. A method for first day calibration (FDC) of a glucose sensor for measuring the level of glucose in a body of a user, said glucose sensor including physical sensor electronics, a microcontroller, and a working electrode, the method comprising: (a) measuring, by said physical sensor electronics, the electrode current (Isig) for the working electrode; (b) determining, by said microcontroller, if the glucose sensor is in a FDC mode of operation following a successful calibration of the glucose sensor; (c) in response to the glucose sensor being in the FDC mode of operation following the successful calibration, determining, by said microcontroller, if the successful calibration was the first calibration of the glucose sensor following insertion of the glucose sensor into the body of the user; (d) in response to the successful calibration of the glucose sensor being the first calibration of the glucose sensor, calculating, by said microcontroller, a calibration ratio (CR) based on said Isig; (e) responsive to determining that the CR was calculated for the first calibration of the glucose sensor, comparing, by the microcontroller, said CR to a threshold range; (f) in response to the CR being outside of the threshold range, setting, by the microcontroller, a next calibration of the glucose sensor to be performed at a first time interval, wherein performance of the next calibration of the glucose sensor performed at the first time interval is based on an electrochemical impedance spectroscopy (EIS) procedure performed via the physical sensor electronics; and (g) in response to the CR being within the threshold range, setting by the microcontroller, the next calibration of the glucose sensor to be performed at a second time interval. 2. The method of claim 1 , wherein said threshold range is 4<CR<7. 3. The method of claim 1 , wherein the second time interval for the next calibration is 3 hours. 4. The method of claim 1 , wherein the first time interval for the next calibration is 6 hours. 5. The method of claim 1 , wherein the first time interval is greater than the second time interval.
Calibrating or testing of in-vivo probes · CPC title
Measuring electrical impedance or conductance of a portion of the body · CPC title
Measuring body composition by impedance, e.g. tissue hydration or fat content · CPC title
for measuring glucose, e.g. by tissue impedance measurement · CPC title
invasive, e.g. introduced into the body by a catheter · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.